Comparative Gene Expression Analysis in the Skeletal Muscles of Dysferlin-deficient SJL/J and A/J Mice
- PMID: 22272044
- PMCID: PMC3234620
- DOI: 10.1293/tox.24.49
Comparative Gene Expression Analysis in the Skeletal Muscles of Dysferlin-deficient SJL/J and A/J Mice
Abstract
Quantitative real-time polymerase chain reaction (qRT-PCR) analysis was conducted to determine whether or not there are interstrain or site-dependent differences in the gene expression profiles of skeletal muscles in SJL/J and A/J mice as dysferlinopathy models. Upon analysis by qRT-PCR, SJL/J mice showed a trend of increased gene expression level of uncoupling protein 2 in the rectus femoris and longissimus lumborum at 30 weeks of age when dystrophic lesions became histopathologically pronounced. Heme oxygenase 1 and S100 calcium binding protein A4 were upregulated in the rectus femoris, longissimus lumborum and abdominal muscles, in which dystrophic lesions occur more commonly in SJL mice. The gene expression levels of heat shock protein 70 in most muscles of A/J mice were lower than those of BALB/c mice as control. SJL/J mice exhibited a marked lowering of decay-accelerating factor 1/CD55 gene expression level in all studied muscles except for the heart at all ages compared with that of BALB/c mice. This study showed that there were some interstrain differences in the gene expres sion profiles of skeletal muscles between SJL/J and A/J mice. Further investigation is required to reveal whether these alterations of the expression levels are the cause of dystrophic changes or occur subsequent to muscle damage.
Keywords: A/J mouse; SJL/J mouse; decay-accelerating factor; dysferlin; heat shock protein; heme oxygenase-1.
Figures


Similar articles
-
Dysferlin and animal models for dysferlinopathy.J Toxicol Pathol. 2012 Jun;25(2):135-47. doi: 10.1293/tox.25.135. J Toxicol Pathol. 2012. PMID: 22907980 Free PMC article.
-
The distribution and characterization of skeletal muscle lesions in dysferlin-deficient SJL and A/J mice.Exp Toxicol Pathol. 2010 Sep;62(5):509-17. doi: 10.1016/j.etp.2009.06.009. Epub 2009 Jul 16. Exp Toxicol Pathol. 2010. PMID: 19615872
-
Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL).Neurosci Res. 2005 May;52(1):47-60. doi: 10.1016/j.neures.2005.01.006. Neurosci Res. 2005. PMID: 15811552
-
The time course of basic fibroblast growth factor expression in crush-injured skeletal muscles of SJL/J and BALB/c mice.Exp Cell Res. 1995 Feb;216(2):325-34. doi: 10.1006/excr.1995.1041. Exp Cell Res. 1995. PMID: 7843277
-
Increased susceptibility to complement attack due to down-regulation of decay-accelerating factor/CD55 in dysferlin-deficient muscular dystrophy.J Immunol. 2005 Nov 1;175(9):6219-25. doi: 10.4049/jimmunol.175.9.6219. J Immunol. 2005. PMID: 16237120
Cited by
-
Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane.Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20831-6. doi: 10.1073/pnas.1307960110. Epub 2013 Dec 3. Proc Natl Acad Sci U S A. 2013. PMID: 24302765 Free PMC article.
-
A tandem repeat in decay accelerating factor 1 is associated with severity of murine mercury-induced autoimmunity.Autoimmune Dis. 2014;2014:260613. doi: 10.1155/2014/260613. Epub 2014 Apr 10. Autoimmune Dis. 2014. PMID: 24818014 Free PMC article.
-
Dysferlin and animal models for dysferlinopathy.J Toxicol Pathol. 2012 Jun;25(2):135-47. doi: 10.1293/tox.25.135. J Toxicol Pathol. 2012. PMID: 22907980 Free PMC article.
-
Genetic silencing of Nrf2 enhances X-ROS in dysferlin-deficient muscle.Front Physiol. 2014 Feb 19;5:57. doi: 10.3389/fphys.2014.00057. eCollection 2014. Front Physiol. 2014. PMID: 24600403 Free PMC article.
-
Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma Developed in a Patient with Progressive Muscular Dystrophy: A Case Report and Review of the Literature.Case Rep Orthop. 2017;2017:3025084. doi: 10.1155/2017/3025084. Epub 2017 May 29. Case Rep Orthop. 2017. PMID: 28634560 Free PMC article.
References
-
- Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve. 23: 1456–1471 2000 - PubMed
-
- Glover L, Brown RH., JrDysferlin in membrane trafficking and patch repair. Traffic. 8: 785–794 2007 - PubMed
-
- Bittner RE, Anderson LV, Burkhardt E, Bashir R, Vafiadaki E, Ivanova S, Raffelsberger T, Maerk I, Hoger H, Jung M, Karbasiyan M, Storch M, Lassmann H, Moss JA, Davison K, Harrison R, Bushby KM, Reis A. Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet. 23: 141–142 1999 - PubMed
-
- Ho M, Post CM, Donahue LR, Lidov HG, Bronson RT, Goolsby H, Watkins SC, Cox GA, Brown RH., JrDisruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency. Hum Mol Genet. 13: 1999–2010 2004 - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous